We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

268:HKEXKingdee International Software Group Co., Ltd. Analysis

Data as of 2026-03-12 - not real-time

₩125,700.00

Latest Price

7/10Risk

Risk Level: Medium

Executive Summary

Miwon Specialty Chemical is trading at 125,700 KRW, well below its 20‑day SMA of 134,720 and the 50‑day SMA of 136,092, indicating a bearish price bias. The RSI sits at 39, hinting at modest oversold pressure, while the MACD histogram is negative and the signal line is labeled bearish, reinforcing the downtrend. Price is hovering just above the identified support level of 122,000 and well beneath the resistance of 145,100, leaving limited upside in the near term. Volatility is elevated at 37.9% over the past 30 days, yet the beta of -0.012 suggests minimal systematic market risk.
Fundamentally, the company generates solid cash flow with 135 bn KRW in cash versus 34 bn KRW of debt, a healthy ROE of 14.4% and a dividend yield of 2.5% supported by a modest payout ratio of 22.8%. However, the DCF‑derived fair value of ≈89,500 KRW is far below the current market price, flagging the stock as overvalued. The sector’s basic‑materials exposure carries medium regulatory and geographic risks, while the stock’s thin trading volume raises a high liquidity concern. Considering the technical weakness, valuation gap, and strong dividend profile, short‑term pressure is likely, but the underlying cash strength and dividend yield could support a longer‑term hold or opportunistic entry if the price corrects.

Market Outlook

Short Term

< 1 year
Cautious
Model confidence: 7/10

Key Factors

  • Bearish technical indicators (price below SMA, negative MACD)
  • Current price exceeds DCF fair value
  • High short‑term volatility

Medium Term

1–3 years
Neutral
Model confidence: 6/10

Key Factors

  • Strong cash position and low debt
  • Attractive dividend yield with sustainable payout
  • Medium sector risk and modest growth prospects

Long Term

> 3 years
Positive
Model confidence: 5/10

Key Factors

  • Solid ROE and cash flow generation
  • Potential price correction toward fair value
  • Dividend income as a value driver

Key Metrics & Analysis

Financial Health

Revenue Growth3.70%
Profit Margin11.21%
ROE14.36%
ROA8.29%
Debt/Equity7.97
Op. Cash Flow₩72.7B
Free Cash Flow₩20.6B

Technical Analysis

TrendBearish
RSI39.3
Support₩122,000.00
Resistance₩145,100.00
MA 20₩134,720.00
MA 50₩136,092.00
MA 200₩142,525.50
MACDBearish
VolumeStable
Fear & Greed Index78.16

Valuation

Fair Value₩89,477.48
GradeOvervalued
TypeValue
Dividend Yield2.51%

Risk Assessment

Beta-0.01
Volatility37.88%
Sector RiskMedium
Reg. RiskMedium
Geo RiskMedium
Currency RiskMedium
Liquidity RiskHigh

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.